Clinical Trials Browser

Withdrawn × Neoplasm Metastasis × Trastuzumab × Clear all

NCT04464967 2021-05-12

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT03811418 2019-11-26

ATTILA

Phase 3 Withdrawn

Tumor-Agnostic

Neoplasm Metastasis

NCT01985893 2016-01-14

THOR

Phase 2 Withdrawn

Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms